SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-16-085617
Filing Date
2016-11-09
Accepted
2016-11-09 16:45:13
Documents
2
Period of Report
2016-11-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1651
2 poaharr.htm EX-24 6314
  Complete submission text file 0001140361-16-085617.txt   9285
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Issuer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 307 WESTLAKE AVE. NORTH, STE. 300 SEATTLE WA 98109
Business Address
Harr Steve (Reporting) CIK: 0001627387 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36562 | Film No.: 161984846